We are live on ! Find out more
SCRX

SCIELE PHARMA INC COM STK
SCRX

Delisted

SCRX was delisted on the 9th of October, 2008.

Back to rankings

1 hedge funds and large institutions have $31 invested in SCIELE PHARMA INC COM STK in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $31 → $31 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$31 – – –

SCRX Hedge Fund Activity: Q2 2025 in Review

1 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in SCIELE PHARMA INC COM STK (SCRX) for Q2 2025, worth a combined $31 — unchanged from a quarter earlier.

Fund positioning in SCRX was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held SCIELE PHARMA INC COM STK (SCRX) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $31 of SCIELE PHARMA INC COM STK stock for Q2 2025, unchanged quarter-over-quarter.
  • 0 funds opened new SCIELE PHARMA INC COM STK positions in Q2 2025 and 0 closed out.

Based on aggregated 13F filings for Q2 2025.